Evaluation of Lymph Nodes for Esophageal Cancer by Dynamic FDG-PET
Not Applicable
- Conditions
- Esophageal Cancer
- Registration Number
- JPRN-UMIN000036683
- Lead Sponsor
- Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients who do not comply with fasting, withdrawal and blood sugar standards at our hospital (2)Patients with much body movement or having severe communication problem (3)Pregnant woman, breastfeeding mother and woman who may be pregnant (4)Patients with a history of hypersensitivity for 18F-FDG
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We measure maximum standardized uptake values (SUVmax) of regions of interest at 60 minutes, and also perform pharmacokinetic analysis. We compare the results of both imaging modalities with the confirmed histopathological diagnoses of each lymph node, and evaluate the diagnostic ability in the detection of lymph node metastasis.
- Secondary Outcome Measures
Name Time Method